European regulators have recommended expanding Maviret, a dual direct-acting antiviral, to include acute hepatitis C infection in adults and children.
Findings showed that in patients treated with glecaprevir/pibrentasvir, the overall SVR12 rate was 96%, with 0 patients experiencing virologic failure. The Food and ...
AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of MAVIRET® ...
AbbVie said the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion recommending the approval of its treatment for acute hepatitis C. The final ...
The FDA expanded the approval of the direct-acting antiviral (DAA) glecaprevir/pibrentasvir (Mavyret), making it the first treatment for acute hepatitis C virus ...
Results of a phase IIIb study found the direct-acting antiviral combination of glecaprevir/pibrentasvir to be highly effective and well tolerated in adults with acute ...
EMA committee recommends approval for AbbVie’s Maviret for the treatment of acute hepatitis C infection: North Chicago, Illinois Monday, May 25, 2026, 18:00 Hrs [IST] AbbVie, an ...
Hepatitis C is a viral infection that affects your liver. You may not have symptoms. Hepatitis C is a viral infection caused by the hepatitis C virus (HCV) that affects the liver. It can be acute or ...
World Hepatitis Day 2020: According to The World Health Organisation, an estimated 40 million people are chronically affected by Hepatitis B and 6 to 12 million people by Hepatitis C in India.
Whether hepatitis resolves depends on the type and whether a person receives treatment. Hepatitis A usually resolves without medications, and while sometimes hepatitis B and C may last only a few ...
An alarming new report has found liver cancer deaths have risen from 1.6 deaths per 100,000 people in the 1980s to 5.1 per 100,000 in 2018–2022.
Hepatitis C virus infection primarily affects the liver but can also damage the kidneys by causing inflammation and reducing their ability to filter waste properly. People with hepatitis C face an ...